issue

Jul 15, 2024

Volume 20 Number 14

This issue of EuroIntervention provides an in-depth State-of-the-Art on all aspects of the clinical durability of TAVI; original research on immediate vs staged revascularisation in STEMI patients; the ULTRACOLOR Trial comparing ultrasound-guided femoral puncture to fluoroscopy-guided large-bore femoral puncture; expanded study results for transapical TMVR; viewpoints on both TAVI in moderate aortic stenosis and on subclinical leaflet thrombosis; the rationale and design of WOEST-3 trial; a first-hand account of the use of the Splitter, a valve leaflet modification device; news from the EAPCI; and more...

Viewpoint

TAVI in moderate aortic stenosis: the earlier the better?
Schofer N, Ludwig S
10.4244/EIJ-D-24-00164
free
Subclinical leaflet thrombosis: should we be concerned?
Dangas G, Bay B
10.4244/EIJ-D-24-00205
free

State-of-the-Art

Durability of transcatheter aortic valve implantation
Ternacle J, Hecht S, Eltchaninoff H, Salaun E, Clavel M-A, Côté N, Pibarot P
10.4244/EIJ-D-23-01050
free

Original Research

Immediate versus staged complete revascularisation in patients presenting with STEMI and multivessel disease
Scarparo P, Elscot JJ, Kakar H, den Dekker WK, Bennett J, Sabaté M, Esposito G, Ranieri De Caterina A, Vandeloo B, Cummins P, Lenzen M, Daemen J, Brugaletta S, Boersma E, Van Mieghem NM, Diletti R, investigators ftB
10.4244/EIJ-D-23-00882
Ultrasound-guided versus fluoroscopy-guided large-bore femoral access in PCI of complex coronary lesions: the international, multicentre, randomised ULTRACOLOR Trial
Meijers T, Nap A, Aminian A, Schmitz T, Dens J, Teeuwen K, van Kuijk J, van Wely M, Bataille Y, Kraaijeveld A, Roolvink V, Dambrink J, Gosselink AM, Hermanides RS, Ottervanger J, Tsilingiris I, van den Buijs DM, van Royen N, van Leeuwen MA
10.4244/EIJ-D-24-00089

Editorial comment

Ultrasound is not the panacea for transfemoral access complications
Jolly S, d'Entremont M
10.4244/EIJ-E-24-00030
free
Clinical outcomes and predictors of transapical transcatheter mitral valve replacement: the Tendyne Expanded Clinical Study
Conradi L, Ludwig S, Sorajja P, Duncan A, Bethea B, Dahle G, Babaliaros V, Guerrero M, Thourani V, Dumonteil N, Modine T, Garatti A, Denti P, Leipsic J, Chuang ML, Blanke P, Muller DW, Badhwar V
10.4244/EIJ-D-23-00904

Trial Design

Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial
Verburg A, Bor WL, Küçük IT, Henriques JP, Vink MA, Ruifrok WT, Plomp J, Heestermans TA, Schotborgh CE, Vlaar PJ, Magro M, Rikken SA, van den Broek WW, van Mieghem CA, Cornelis K, Rosseel L, Dujardin KS, Vandeloo B, Vandendriessche T, Ferdinande B, van ’t Hof AW, Tijssen JG, Limbruno U, De Caterina R, Rubboli A, Angiolillo DJ, Adriaenssens T, Dewilde W, ten Berg JM
10.4244/EIJ-D-24-00100

Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved